This compound is a modified nucleoside phosphoramidite building block used in the solid-phase synthesis of oligonucleotides. Its structure features multiple protective groups, including a dimethoxytrityl (DMT) group for 5'-hydroxyl protection and a cyanoethyl phosphoramidite moiety for internucleotide linkage formation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 206055-82-5
DMTr-LNA-C(Bz)-3-CED-phosphoramidite
research compound
1-(2,5-Anhydro-4-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-O-{(2-cyanoethoxy)[di(propan-2-yl)amino]phosphanyl}-6-deoxy-alpha-L-mannofuranosyl)-4-benzamido-5-methylpyrimidin-2(1H)-one
pharmaceutical intermediate
(1R,3R,4R,7S)-3-(6-N-Benzoyladenin-9-yl)-7-(2-cyanoethoxy(diisopropylamino)phosphinoxy)-1-(4,4'-dimethoxytrityloxymethyl)-2,5-dioxabicyclo(2.2.1)heptane
research compound
Dmt-loct phosphoramidite
research compound
5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
Boc-His(Trt)-Aib-OH
pharmaceutical intermediate
Edaravone Impurity 12
pharmaceutical intermediate
(E)-2-(trifluoromethyl)cinnamic acid
pharmaceutical intermediate
N-[1-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
XHILZPWJJJDDDY-HXAWEXODSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3[C@H]4[C@@H]([C@@](O3)(CO4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)OP(N(C(C)C)C(C)C)OCCC#N
—